antibody screening

Posted by Catalina Garcia on March 23rd, 2024

Creative Biolabs offers a series of AI-based antibody screening services based on the prediction of antibody-antigen binding. We offer a unique way to find rare antibody clusters and get more candidate antibody sequences by augmenting our data-driven AI screening services.

Why AI-based Antibody Screening?

Every year 2500 discovery projects fail to find strong binders with biological effects because of insufficient diversity: in vitro screening starts with a limited set of antibodies and 90% of the binders are lost due to limitations of the process. New antibody panels generated by AI are a source of candidates with new binding modalities and potentially new therapeutic modes-of-action. Typically, AI screening can generate 10 times more antibody sequence clusters than a laboratory-based approach alone, resulting in increased diversity of antibody sequences and target epitope binding which equals greater opportunity to optimize receptor agonism.